The National Institute for Health and Care Excellence (NICE) is a world-leading producer of high-quality evidence syntheses to inform the development of national guidelines. Their aim is to facilitate links to the underpinning evidence and support shared decision making between patients and professionals through use of interactive, living guideline recommendations. To realise this vision NICE is committed to developing collaborative links with organisations such as Cochrane, wherever feasible, to support timely production, uptake and reduced duplication of high-quality evidence syntheses.
This session explored the opportunities, challenges and mechanisms that are in place to support mutually beneficial collaborative efforts. They illustrated this with a recent example where NICE worked with the Cochrane Tobacco Addiction Group to support the update of the ‘Tobacco: preventing uptake, promoting quitting and treating dependence’ guideline. Perspectives on collaboration were provided from the viewpoint of the NICE developer, the Cochrane reviewers, and the NICE Guideline committee.
Speakers
Clare Wohlgemuth
Senior Technical Analyst, Methods and Economics Team, Centre for Guidelines at NICE
.
Toby Lasserson
Deputy Editor in Chief, Cochrane Library
.
Kasia Campbell
Research Fellow and Trial Manager, the University of Nottingham
.
.